04.02.07
MedImmune, Inc. has promoted three senior leaders within its R&D and medical organizations. The new executive appointments include Iksung Cho, vice president, biostatistics; Anthony J. Coyle, Ph.D., vice president, R&D, and head, inflammation and autoimmunity research; and Barbara White, M.D., vice president, clinical development, inflammatory disease.
Mr. Cho will manage a team of almost 20 statisticians who conduct activities such as clinical trial design and analysis for the company's research, development, clinical, regulatory and manufacturing organizations. He previously served as the primary statistician for Aviron's influenza vaccine program. MedImmune acquired Aviron in 2002. Prior to that, Mr. Cho worked at Merck Research Labs within the vaccines development group.
Dr. Coyle will oversee MedImmune's preclinical research in disease areas such as asthma, lupus, rheumatoid arthritis and sepsis. Prior to joining the company as a senior director in 2005, he served as director, inflammation biology, at Millennium Pharmaceuticals in Cambridge, MA. He also worked as a research scientist in the immunology department at the Glaxo Institute for Molecular Biology in Geneva, Switzerland. He has more than six years of experience as a post-doctoral research assistant in immunology and pharmacology at Institut Pasteur in Paris and the National Jewish Center of Immunology in Denver.
Dr. White joined the company in January 2006 as senior director, and was appointed head of the inflammatory disease group in clinical development in November 2006. Prior to joining the company, she was a director of medical affairs, inflammation therapeutic area, at Amgen where her activities included leading non-registration internal and external clinical research programs. Prior to 2003, Dr. White served as professor of medicine in the division of rheumatology, department of medicine, at the University of Maryland School of Medicine. She was formerly associate chief of staff of the research service at the Baltimore Veteran Administration (VA) Medical Center, where her research focused on immune-mediated mechanisms of lung fibrosis in scleroderma. Dr. White also served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. She has been active in the American College of Rheumatology and has served as an ad hoc member of the FDA Arthritis Advisory Committee.
Mr. Cho will manage a team of almost 20 statisticians who conduct activities such as clinical trial design and analysis for the company's research, development, clinical, regulatory and manufacturing organizations. He previously served as the primary statistician for Aviron's influenza vaccine program. MedImmune acquired Aviron in 2002. Prior to that, Mr. Cho worked at Merck Research Labs within the vaccines development group.
Dr. Coyle will oversee MedImmune's preclinical research in disease areas such as asthma, lupus, rheumatoid arthritis and sepsis. Prior to joining the company as a senior director in 2005, he served as director, inflammation biology, at Millennium Pharmaceuticals in Cambridge, MA. He also worked as a research scientist in the immunology department at the Glaxo Institute for Molecular Biology in Geneva, Switzerland. He has more than six years of experience as a post-doctoral research assistant in immunology and pharmacology at Institut Pasteur in Paris and the National Jewish Center of Immunology in Denver.
Dr. White joined the company in January 2006 as senior director, and was appointed head of the inflammatory disease group in clinical development in November 2006. Prior to joining the company, she was a director of medical affairs, inflammation therapeutic area, at Amgen where her activities included leading non-registration internal and external clinical research programs. Prior to 2003, Dr. White served as professor of medicine in the division of rheumatology, department of medicine, at the University of Maryland School of Medicine. She was formerly associate chief of staff of the research service at the Baltimore Veteran Administration (VA) Medical Center, where her research focused on immune-mediated mechanisms of lung fibrosis in scleroderma. Dr. White also served as co-director of the Johns Hopkins University and University of Maryland Scleroderma Center. She has been active in the American College of Rheumatology and has served as an ad hoc member of the FDA Arthritis Advisory Committee.